Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FAZBE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,678
Award facts
- Contract value 100% obligated
- $16,678.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,678.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count units). The award, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. DMS Pharmaceutical Group was selected based on its competitive capability to fulfill this requirement within the Defense Logistics Agency's existing pharmaceutical procurement framework, demonstrating the company's continued role as a critical supplier within the federal military medical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition vehicle designed to streamline pharmaceutical procurement for Department of Defense healthcare facilities worldwide. The PPV-G GEN V represents a strategic sourcing initiative that establishes multiple regional prime vendor contractors to supply comprehensive pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables, supporting recurring medical supply needs across global military healthcare operations. DMS Pharmaceutical Group's selection as a prime vendor contractor, combined with its demonstrated performance across numerous delivery orders issued since October 2025, positions the company as a key pharmaceutical distributor for DoD medical supply requirements.
Quick answers
Who was awarded contract SPE2DB26FAZBE?
SPE2DB26FAZBE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FAZBE worth?
The government has obligated $16,678 on SPE2DB26FAZBE.
Is contract SPE2DB26FAZBE an order under another contract?
Yes. SPE2DB26FAZBE is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB26FAZBE competed?
The extent of competition for SPE2DB26FAZBE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award